Skip to main content

AVATAR2 Therapy for auditory hallucinations

EDM (Early Day Motion) 1354: tabled on 14 January 2021

Tabled in the 2019-21 session.

This motion has been signed by 8 Members. It has not yet had any amendments submitted.

Motion text

That this House recognises that mental health treatment and support has never been more important; acknowledges AVATAR therapy as a new approach to working with people experiencing distressing auditory hallucinations; notes the success of the first trial in South London and the launch of the new multi-site trial of AVATAR2 at Glasgow University, Manchester University, University College London and Kings College London supported by the Wellcome Trust, under the esteemed leadership of Professors Philippa Garety, Tom Craig, Andrew Gumley, Hamish McLeod, Sandra Bucci, Gillian Haddock and Dr. Miriam Fornells-Ambrojo; and welcomes that digital approaches will increase access to psychological interventions for people who require mental health treatment, particularly during the covid19 outbreak.